Federal government to purchase additional 100 million doses of Johnson & Johnson’s COVID-19 vaccine
President Biden, citing the need for maximum flexibility in the nation’s vaccination program, today announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.
Johnson & Johnson is working with Merck to increase supply, making such a deal possible.
The purchase doubles the nation’s projected supply of Johnson & Johnson doses, to 200 million. The intent of the purchase is to prepare for long-term supply needs, including the eventual vaccination of children and the possible need for booster shots to protect against COVID-19 variants.
Related News Articles
Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…